retatrutide clinical trial weight loss results 2024 2025 press release Lilly's retatrutide shows 28% weight loss Retatrutide for weight loss: Study
Description
GLP-1 receptors demonstrate widespread but selective distribution throughout the central nervous system
While traditional therapies such as statins suppress the functioning of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, recent attention has turned toward GLP-1 RAs effects on modulating lipid profiles
& Mule, F
Front Endocrinol (Lausanne) 11:617400 McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
World Health Organization (2016) Diabetes Fact Sheet
(Hercules, CA, USA)
